cannabis and semaglutide GLP-1 medications get at the heart of addiction: study – WashU Medicine Regular marijuana use may increase
Description
Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release
147 (3), 373e381e
Discovery of GLP-1 In 1923, Charles Kimball and John Murlin, in an attempt to purify commercial insulin, precipitated a pancreatic fraction that had a hyperglycemic effect (8)
There may, of course, be individual reasons why a person with type 2 diabetes and CKD might benefit from incretin mimetics
